DUONEB Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Duoneb, and when can generic versions of Duoneb launch?
Duoneb is a drug marketed by Mylan Speciality Lp and is included in one NDA.
The generic ingredient in DUONEB is albuterol sulfate; ipratropium bromide. There are thirty-eight drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the albuterol sulfate; ipratropium bromide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Duoneb
A generic version of DUONEB was approved as albuterol sulfate; ipratropium bromide by CIPLA on December 31st, 2007.
Summary for DUONEB
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 3 |
Clinical Trials: | 2 |
Formulation / Manufacturing: | see details |
DailyMed Link: | DUONEB at DailyMed |
Recent Clinical Trials for DUONEB
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University Hospitals Cleveland Medical Center | Phase 1 |
Shin-hwar Wu | N/A |
Anatomical Therapeutic Chemical (ATC) Classes for DUONEB
US Patents and Regulatory Information for DUONEB
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mylan Speciality Lp | DUONEB | albuterol sulfate; ipratropium bromide | SOLUTION;INHALATION | 020950-001 | Mar 21, 2001 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for DUONEB
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Mylan Speciality Lp | DUONEB | albuterol sulfate; ipratropium bromide | SOLUTION;INHALATION | 020950-001 | Mar 21, 2001 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for DUONEB
See the table below for patents covering DUONEB around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Japan | 2006505486 | ⤷ Sign Up | |
Japan | 2010184937 | ALBUTEROL AND IPRATROPIUM INHALATION SOLUTION FOR RELIEVING SYMPTOM OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, KIT, METHOD FOR PREPARING ONE VESSEL CONTAINING THE INHALATION SOLUTION AND METHOD FOR PREPARING THE INHALATION SOLUTION | ⤷ Sign Up |
World Intellectual Property Organization (WIPO) | 2006078636 | ⤷ Sign Up | |
Canada | 2464735 | SOLUTION D'INHALATION A BASE D'ALBUTEROL ET D'IPRATROPIUM, ET SYSTEME, KIT ET METHODE PERMETTANT DE SOULAGER LES SYMPTOMES DE LA BRONCHOPNEUMOPATHIE CHRONIQUE OBSTRUCTIVE (AN ALBUTEROL AND IPRATROPIUM INHALATION SOLUTION, SYSTEM, KIT AND METHOD FOR RELIEVING SYMPTOMS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE) | ⤷ Sign Up |
Japan | 2010235617 | METHOD FOR PREPARING ALBUTEROL AND IPRATROPIUM INHALATION SOLUTION FOR RELIEVING SYMPTOM OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, AND PREPACKAGE TREATMENT SYSTEM | ⤷ Sign Up |
European Patent Office | 1446045 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |